Jupiter Neurosciences Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Jupiter Neurosciences Inc (JUNS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Jupiter Neurosciences Inc vs Its Competitors
- Scale: Jupiter Neurosciences Inc ranks #449 of 543 companies by market capitalization in the Major Pharmaceutical Preparations industry, holding 0.0% of industry market cap.
- Peer revenue share: Jupiter Neurosciences Inc accounted for 100.0% of combined revenue among its tracked peer group.
- Structure: Jupiter Neurosciences Inc operates in the following segments: Premium Nutritional Supplements, Pharmaceutical Operations, Corporate and Other.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
JUNS Sales vs. its Competitors, Q2 2026
Jupiter Neurosciences Inc generated 100.00 % of the combined sales of its peer group.
API endpoints for this dataset
Jupiter Neurosciences Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Jupiter Neurosciences Inc | - | - | - | Yes |
| High-Confidence Competitors (5) | ||||
| Similar-Size Competitors (10) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
JUNS Stock Performance relative to its Competitors
JUNS Stock Performance relative to High-Confidence Competitors
JUNS Stock Performance relative to Similar-Size Competitors
Jupiter Neurosciences Inc's Comment on Competition and Industry Peers
Jupiter Neurosciences Inc's Competitors Named by the Company
Competitive relationships identified from Jupiter Neurosciences Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Sigilon Therapeutics, Inc. | Company report | 85% |
| Sangamo Therapeutics, Inc. | Company report | 85% |
| Reata Pharmaceuticals | Company report | 85% |
| Biogen | Company report | 85% |
| Sanofi Genzyme | Company report | 85% |
| RegenexBio | Company report | 85% |
| Minoryx Therapeutics | Company report | 85% |
Company report basis, confidence, active dates and source counts for Jupiter Neurosciences Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Jupiter Neurosciences Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Jupiter Neurosciences Inc | Premium Nutritional Supplements 100.00 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).